Journal of Internal Medicine

Paracetamol hepatotoxicity at therapeutic doses
pp. 95-98(4)
Author: S. Vitols

The risk of thrombolysis in association with cardiopulmonary resuscitation: no reason to withhold this causal and effective therapy
pp. 99-101(3)
Authors: B. W. Böttiger; F. Spöhr

Helicobacter pylori: resurrection of the cancer link
pp. 102-119(18)
Authors: B. Björkholm; P. Falk; L. Engstrand; O. Nyrén

The molecular genetics of cardiovascular disease: clinical implications
pp. 120-127(8)
Authors: J. W. Stephens; S. E. Humphries

Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment
pp. 128-135(8)
Authors: I. Kurkciyan; G. Meron; F. Sterz; M. Müllner; K. Tobler; H. Domanovits; W. Schreiber; H. C. Bankl; A. N. Laggner

Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: The Malmö Preventive Project
pp. 136-145(10)
Authors: P. Nilsson; J-Å. Nilsson; B. Hedblad; K-F. Eriksson; G. Berglund

Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study
pp. 146-152(7)
Authors: A.-M. Hvas; S. Juul; E. Nexø; J. Ellegaard

Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality
pp. 153-160(8)
Authors: C. Löwbeer; P. Stenvinkel; R. Pecoits-Filho; O. Heimbürger; B. Lindholm; S. A. Gustafsson; A. Seeberger

Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia
pp. 161-168(8)
Authors: P. R. W. De Sauvage Nolting; J. C. Defesche; R. J. A. Buirma; B. A. Hutten; P. J. Lansberg; J. J. P. Kastelein

What cause of mortality can we predict by cholesterol screening in the Japanese general population?
pp. 169-180(12)
Authors: T. Okamura; T. Kadowaki; T. Hayakawa; Y. Kita; A. Okayama; H. Ueshima

Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial
pp. 181-188(8)
Authors: D. Melchart; J. Thormaehlen; S. Hager; J. Liao; K. Linde; W. Weidenhammer

Validation of a glucose–insulin–potassium infusion algorithm in hospitalized diabetic patients
pp. 189-193(5)
Authors: M. Bonnier; P. Lönnroth; S. Gudbjörnsdottir; S. Attvall; P.-A. Jansson

Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis
pp. 194-200(7)
Authors: G. Mossetti; P. Vuotto; D. Rendina; F. G. Numis; R. Viceconti; F. Giordano; M. Cioffi; F. Scopacasa; V. Nunziata

No acute impact of haemodialysis treatment on free radical scavenging enzyme gene expression in white blood cells
pp. 201-207(7)
Authors: V. Schettler; W. Kühn; T. Kleinoeder; V. W. Armstrong; M. Oellerich; G. A. Müller; E. Wieland

Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency
pp. 208-216(9)
Authors: S. Kaser; A. Sandhofer; B. Hölzl; R. Gander; C. F. Ebenbichler; B. Paulweber; J. R. Patsch

A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis
pp. 217-224(8)
Authors: E. Cadet; D. Capron; A. S. Perez; S. N. Crépin; S. Arlot; J.-P. Ducroix; M. Dautréaux; P. Fardellone; P. Leflon; A. T. Merryweather-Clarke; K. J. Livesey; J. J. Pointon; P. Rose; J. Harcourt; J. Emery; J. M. Sueur; R. Feyt; K. J. H. Robson; J. Rochette

Effects of glucocorticoids on leptin levels and eating behaviour in women
pp. 225-231(7)
Authors: J. Uddén; P. Björntorp; P. Arner; B. Barkeling; L. Meurling; S. Rössner

Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and -cell function
pp. 232-239(8)
Authors: I. Os; A. Høieggen; A. Larsen; P. M. Sandset; S. Djurovic; K. Berg; A. Os; K. Birkeland; A. Westheim

Paracetamol-induced hepatotoxicity at recommended dosage
pp. 240-243(4)
Authors: J. Kurtovic; S. M. Riordan

Clinical relevance of isoproterenol challenge in tilt table testing in a patient with nonspecific repolarization abnormalities and exercise-induced syncope
pp. 244-246(3)
Authors: M. F. Márquez; A. N. Sobrino; L. Romero-Ayala; H. Charfeddine; F. Hidden-Lucet; J. Tonet; R. Frank

Facial flushing and localized Castleman's disease: an extension of the POEMS syndrome phenotype
pp. 247-248(2)
Authors: Y. T. Ma; S. J. Weatherby; D. G. Rao; J. B. Winer; C. Craddock; A. C. Williams

Facial flushing and localized Castleman's disease: an extension of the POEMS syndrome phenotype – reply
pp. 249-249(1)
Authors: Y. Kihara; T. Hamada; M. Otsuki

Diagnostic and prognostic role of cardiac troponins
pp. 250-250(1)
Authors: P. J. Riga; D. W. Shenenberger

Instructions for authors
pp. 251-252(2)